Pharmacokinetics of Digoxin: Interpreting Bioavailability

31Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

Three subjects were first given a digoxin tablet in the fasting state and subsequently received the same formulation in the fed state, to simulate a spurious oral bio-availability difference. As expected, when measured by peak serum digoxin concentration as well as by area under the serum digoxin concentration-time curve the bioavailability of digoxin appeared to be higher in the fasting state than in the fed state. However, when measured by cumulative five-day urinary excretion of digoxin bioavailability was identical in both conditions. This simple experiment illustrates the fact that the estimation of bioavailability is subject to considerable methodological error, of which the clinician must be aware when evaluating reports on drug bioavailability in general and of digoxin in particular. © 1973, British Medical Journal Publishing Group. All rights reserved.

Cite

CITATION STYLE

APA

Sanchez, N., Sheiner, L. B., Halkin, H., & Melmon, K. L. (1973). Pharmacokinetics of Digoxin: Interpreting Bioavailability. British Medical Journal, 4(5885), 132. https://doi.org/10.1136/bmj.4.5885.132

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free